Keyword
Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Types of COPD: Symptoms, Treatments, and More
2 Korean Quality Assessment Program Found to Be Effective at Improving COPD Care
3 COVID-19 Has Devastating Effects for Patients Suffering From COPD
4 Stage 1 COPD: Symptoms, treatment, and outlook
5 UK Study Finds Off-Label Prescribing of COPD Therapies Is Low
6 Beta-Blockers May Reduce COPD Exacerbations Without Negative Effect on Mortality
7 Improvement in lung function and patient-reported outcomes i | COPD
8 Review on Blended Self-management Shows Mixed Results on Relieving COPD Burden
9 EP. 6: Dr Nicola Hanania on the Future of COPD Research
10 Treatable Traits and Eosinophil Counts: Drug Therapy in COPD
11 Chest CT Accurate in Estimating All-Cause COPD Mortality Risk
12 Long-Term Pulmonary Rehabilitation Maintenance Program Can Be Beneficial in COPD
13 Researchers Identify Patients With COPD at Risk for Hypercapnia Development
14 COPD Stakeholder Summit—Individualizing Treatment and Improving Outcomes, Part 2
15 Paradoxical Effect From Bronchodilators Linked to Worse Quality of Life in COPD
16 Study Finds Depression, Anxiety to Be More Common in COPD Than Other Chronic Comorbidities
17 Chest CT illuminates mortality risk in people with COPD
18 What is shortness of breath? Causes and when to contact a doctor
19 CT-derived body composition assessment may signal mortality risk in COPD
20 Nonmedical Switching Led to Gaps in COPD Care, Study Says
21 Tiny Lung Valve Eases Breathing in Emphysema/COPD Patients
22 Construction Workers Are at an Increased Risk for COPD
23 Noninvasive ventilation acutely improves endothelial function in exacerbated COPD patients
24 Long-Term Exposure to Particulate Matter Increases CV Mortality Risk in COPD
25 Study Finds 3-Fold Higher Care Costs for Patients With COPD Than Healthy Patients
26 Possible Value in Using Clinically Important Deterioration as COPD Prognosis Indicator
27 Study Links Risk of Excessive Blood CO2 to Certain COPD Complications
28 Respiratory Symptoms Questionnaire Validated Tool for Asthma and/or COPD
29 Circ-OSBPL2 contributes to smoke-related COPD | COPD
30 [Full text] CHARACTERISTICS OF COPD PHENOTYPES IN SERBIA | COPD
31 Virtual Pulmonary Rehabilitation Programs for COPD Must Continue to Address Patient Access
32 TLD helping COPD patients to breathe easier
33 UArizona researching personalized treatments for COPD
34 COPD and COVID-19: Risks, Complications, Considerations
35 Easyhaler Use in COPD or Asthma Generates Sufficient Inspiratory Flows
36 Predicting Hospitalization Due to COPD Exacerbations in Swedish Primar | COPD
37 Chest CT Indicates Mortality Risk in COPD
38 Emphysema underdiagnosed, but low-dose CT provides opportunity to identify, intervene
39 Cough Systems Market Growth Pursuant to Rising COPD Burden Worldwide
40 Fungi are present in your lungs
41 A Pandemic Spotlight on COPD
42 Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease i | COPD
43 COPD Foundation, DevPro Biopharma Partner to Boost New Therapy...
44 COPD rehabilitation in Veterans' homes bolstered by VA Video Connect
45 Eosinophilic COPD Exacerbations Not Predictive of Moderate, Severe Relapses
46 [Full text] Digital Resources to Support COPD Self-Management | JMDH
47 2 Distinct Patterns of Coexisting Disorders Observed in COPD, Study Says
48 Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
49 Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
50 Long-term air pollution exposure may elevate risk for CV mortality in patients with COPD
51 COPD Foundation and DevPro Biopharma Join Forces to Develop Treatments for People with COPD and Related Lung Conditions
52 Pulmonary rehabilitation confers long-term benefits in patients with COPD
53 Prediction of Mortality Using Different COPD Risk Assessments – | COPD
54 Study of Lung Health Among Blacks Earns CHEST Foundation Grant
55 FDA Approval Sought for New Generic Version of Advair Diskus
56 Health care affordability, racial disparities persist in individuals with asthma, COPD
57 You've Got Fungi in Your Lungs, and That's OK
58 Outcomes Poorer for PH-COPD Than Idiopathic PAH, Registry Data Show
59 Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
60 Noninvasive Ventilation During Sleep May Be Beneficial for Patients With COPD
61 Acute Viral Infections May Lead to COPD via Sentinel Immune Cells
62 Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD
63 Chronic Obstructive Pulmonary Disorder (COPD) Market 2021 Analysis and Precise Outlook – 2026; GSK, Pfizer, Merck, Novartis, AstraZeneca, Boehringer Ingelheim – KSU | The Sentinel Newspaper
64 Effects of influenza vaccination on clinical outcomes of chronic obstructive pulmonary disease: A systematic review and meta-analysis
65 Pharmaceutical Intermediates Market to see growth
66 Nashville woman with lung disease issues plea for help with flooding issue at residence
67 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market expected to expand at a CAGR of ~5% during the forecast period of 2019 to 2027 – KSU | The Sentinel Newspaper
68 COPD Drugs Market Key Business Opportunities, Impressive Growth Rate and Development Analysis to 2026 – SoccerNurds
69 Virtual 'Cycle the Seacoast' raises funds for lung disease
70 Global Drugs for Asthma and COPD Market 2021 Development Analysis – GSK, Pfizer, Novartis, Abbott, Boehringer Ingelheim, Merck, Teva, AstraZeneca – KSU | The Sentinel Newspaper
71 Global COPD Devices Market latest Industry Developments and Future Growth Opportunities – KSU | The Sentinel Newspaper
72 Global Asthma & COPD Market Key Trends Analysis and Strategic Analysis Forecast 2021- 2026
73 There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)
74 Global COPD & Asthma Devices Market Growth/Extension is expected to amplify market Key Trends, Growth Demand and Leading Players Anlysis by 2020-2027
75 The Search for new COPD Therapies
76 5 Early-Life Risk Factors for COPD
77 Interactives Case Studies (March 2021)
78 Consider New Treatment Options for COPD
79 Top 5 Most-Read COPD Stories of 2020
80 Your Lungs Are Teeming With Fungi, And That's Not Necessarily A Bad Thing
81 COPD Before the Age of 50 Often Associated With Family History, Study Says
82 EP. 1: COPD & COVID-19: An Interview With Dr MeiLan Han
83 Asthma and COPD Drugs Market to Exhibit Continuous Growth till 2027 | Players – Boehringer Ingelheim, Novartis AG, GlaxoSmithKline, Merck and Co. – KSU | The Sentinel Newspaper
84 Types and stages of COPD: Symptoms, causes, and more
85 Doctors' Group Says Antibiotics Can Be Taken for Shorter Periods
86 Does COPD Progress after Quitting Smoking: Your FAQs
87 Are Patients With COPD More Vulnerable to COVID-19?
88 Respiratory Drugs Market Size 2021 | Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast Report 2021-2028
89 COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says
90 Study Finds Variation in COPD Characteristics by Risk Factors
91 Rapid AI Penetration to Drive Growth of Global MR Vital Sign Monitors Market
92 Science: The app helps COPD patients take the necessary measures if the disease gets worse
93 Targeting Chronic Obstructive Pulmonary Disease Endotypes
94 COPD and the microbiome
95 COPD and cough: Link, treatment, and more
96 FDA Grants 510(k) Clearance to Pulsehaler for Respiratory Disease Relief
97 COVID-19 With COPD: Fewer Hospitalizations, But Greater Mortality
98 Drowning in fear? Reach for God’s hand in the ‘storm’
99 Diagnostic accuracy of lung point-of-care ultrasonography for acute heart failure compared with chest x-ray study among dyspneic older patients in the emergency department
100 The Need for New Biological Targets for Therapeutic Intervention in COPD